ArticleCellular and molecular life sciences : CMLS2024
PARVB deficiency alleviates cisplatin-induced tubular injury by inhibiting TAK1 signaling.
Aihua Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it